Moderna
MRNA
#1830
Rank
$10.82 B
Marketcap
$27.70
Share price
8.67%
Change (1 day)
-37.67%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -$3.15 Billion USD

According to Moderna 's latest financial reports the company's current earnings are $2.20 Billion USD. In 2024 the company made an earning of -$3.59 Billion USD, an increase over its 2023 earnings that were of -$3.91 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$3.15 Billion-12.22%
2024 -$3.59 Billion-8.22%
2023 -$3.91 Billion-140.65%
2022 $9.60 B-27.81%
2021 $13.30 B-1911.15%
2020 -$0.74 Billion44.7%
2019 -$0.51 Billion28.63%
2018 -$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-$47.43 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$41.77 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.13 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-$75.08 Million-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA